Northern Trust Corp Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Northern Trust Corp boosted its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 327,815 shares of the medical instruments supplier’s stock after acquiring an additional 15,843 shares during the quarter. Northern Trust Corp owned 1.46% of LeMaitre Vascular worth $30,205,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of LMAT. Smartleaf Asset Management LLC boosted its stake in shares of LeMaitre Vascular by 234.4% during the fourth quarter. Smartleaf Asset Management LLC now owns 418 shares of the medical instruments supplier’s stock valued at $39,000 after purchasing an additional 293 shares during the period. CBIZ Investment Advisory Services LLC boosted its position in LeMaitre Vascular by 38.5% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier’s stock valued at $39,000 after buying an additional 117 shares during the period. KBC Group NV grew its stake in LeMaitre Vascular by 58.4% in the 4th quarter. KBC Group NV now owns 1,112 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 410 shares in the last quarter. Huntington National Bank increased its position in shares of LeMaitre Vascular by 64.9% during the fourth quarter. Huntington National Bank now owns 1,156 shares of the medical instruments supplier’s stock worth $107,000 after acquiring an additional 455 shares during the period. Finally, Empowered Funds LLC bought a new stake in shares of LeMaitre Vascular during the fourth quarter valued at approximately $150,000. Institutional investors own 84.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on LMAT shares. Lake Street Capital upped their target price on LeMaitre Vascular from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Oppenheimer cut shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Barrington Research lowered shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Finally, Wells Fargo & Company initiated coverage on shares of LeMaitre Vascular in a research note on Thursday, February 13th. They set an “equal weight” rating and a $95.00 price objective on the stock. Five analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, LeMaitre Vascular currently has an average rating of “Moderate Buy” and a consensus target price of $98.14.

LeMaitre Vascular Stock Down 1.6 %

NASDAQ LMAT opened at $80.20 on Friday. LeMaitre Vascular, Inc. has a 52 week low of $71.42 and a 52 week high of $109.58. The company has a 50 day moving average price of $84.15 and a 200 day moving average price of $93.09. The firm has a market cap of $1.81 billion, a PE ratio of 43.83, a price-to-earnings-growth ratio of 2.22 and a beta of 0.86.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.02). The business had revenue of $59.87 million for the quarter, compared to analyst estimates of $57.61 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The business’s revenue for the quarter was up 12.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.44 earnings per share. On average, equities research analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.20 per share. The ex-dividend date is Thursday, May 15th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.00%. LeMaitre Vascular’s payout ratio is 40.40%.

Insider Activity

In other LeMaitre Vascular news, insider Trent G. Kamke sold 2,009 shares of the company’s stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $82.12, for a total transaction of $164,979.08. Following the transaction, the insider now owns 5,564 shares in the company, valued at approximately $456,915.68. This represents a 26.53 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 10.79% of the company’s stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.